Literature DB >> 20664045

Delirium in elderly patients and the risk of postdischarge mortality, institutionalization, and dementia: a meta-analysis.

Joost Witlox1, Lisa S M Eurelings, Jos F M de Jonghe, Kees J Kalisvaart, Piet Eikelenboom, Willem A van Gool.   

Abstract

CONTEXT: Delirium is a common and serious complication in elderly patients. Evidence suggests that delirium is associated with long-term poor outcome but delirium often occurs in individuals with more severe underlying disease.
OBJECTIVE: To assess the association between delirium in elderly patients and long-term poor outcome, defined as mortality, institutionalization, or dementia, while controlling for important confounders. DATA SOURCES: A systematic search of studies published between January 1981 and April 2010 was conducted using the databases of MEDLINE, EMBASE, PsycINFO, and CINAHL. STUDY SELECTION: Observational studies of elderly patients with delirium as a study variable and data on mortality, institutionalization, or dementia after a minimum follow-up of 3 months, and published in the English or Dutch language. Titles, abstracts, and articles were reviewed independently by 2 of the authors. Of 2939 references in the original search, 51 relevant articles were identified. DATA EXTRACTION: Information on study design, characteristics of the study population, and outcome were extracted. Quality of studies was assessed based on elements of the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist for cohort studies. DATA SYNTHESIS: The primary analyses included only high-quality studies with statistical control for age, sex, comorbid illness or illness severity, and baseline dementia. Pooled-effect estimates were calculated with random-effects models. The primary analysis with adjusted hazard ratios (HRs) showed that delirium is associated with an increased risk of death compared with controls after an average follow-up of 22.7 months (7 studies; 271/714 patients [38.0%] with delirium, 616/2243 controls [27.5%]; HR, 1.95 [95% confidence interval {CI}, 1.51-2.52]; I(2), 44.0%). Moreover, patients who had experienced delirium were also at increased risk of institutionalization (7 studies; average follow-up, 14.6 months; 176/527 patients [33.4%] with delirium and 219/2052 controls [10.7%]; odds ratio [OR], 2.41 [95% CI, 1.77-3.29]; I(2), 0%) and dementia (2 studies; average follow-up, 4.1 years; 35/56 patients [62.5%] with delirium and 15/185 controls [8.1%]; OR, 12.52 [95% CI, 1.86-84.21]; I(2), 52.4%). The sensitivity, trim-and-fill, and secondary analyses with unadjusted high-quality risk estimates stratified according to the study characteristics confirmed the robustness of these results.
CONCLUSION: This meta-analysis provides evidence that delirium in elderly patients is associated with poor outcome independent of important confounders, such as age, sex, comorbid illness or illness severity, and baseline dementia.

Entities:  

Mesh:

Year:  2010        PMID: 20664045     DOI: 10.1001/jama.2010.1013

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  487 in total

1.  Postoperative delirium: a 76-year-old woman with delirium following surgery.

Authors:  Edward R Marcantonio
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

2.  Epigenetics of neuroinflammation: Immune response, inflammatory response and cholinergic synaptic involvement evidenced by genome-wide DNA methylation analysis of delirious inpatients.

Authors:  Taku Saito; Hiroyuki Toda; Gabrielle N Duncan; Sydney S Jellison; Tong Yu; Mason J Klisares; Sophia Daniel; Allison J Andreasen; Lydia R Leyden; Mandy M Hellman; Eri Shinozaki; Sangil Lee; Aihide Yoshino; Hyunkeun R Cho; Gen Shinozaki
Journal:  J Psychiatr Res       Date:  2020-06-06       Impact factor: 4.791

3.  Enhancing care for hospitalized older adults with cognitive impairment: a randomized controlled trial.

Authors:  Malaz A Boustani; Noll L Campbell; Babar A Khan; Greg Abernathy; Mohammed Zawahiri; Tiffany Campbell; Jason Tricker; Siu L Hui; John D Buckley; Anthony J Perkins; Mark O Farber; Christopher M Callahan
Journal:  J Gen Intern Med       Date:  2012-05       Impact factor: 5.128

Review 4.  Delirium in hospitalized patients: implications of current evidence on clinical practice and future avenues for research--a systematic evidence review.

Authors:  Babar A Khan; Mohammed Zawahiri; Noll L Campbell; George C Fox; Eric J Weinstein; Arif Nazir; Mark O Farber; John D Buckley; Alasdair Maclullich; Malaz A Boustani
Journal:  J Hosp Med       Date:  2012-06-08       Impact factor: 2.960

Review 5.  Non-pharmacological approaches in the prevention of delirium.

Authors:  Fabio Salvi; John Young; Moira Lucarelli; Alessandra Aquilano; Riccardo Luzi; Giuseppina Dell'Aquila; Antonio Cherubini
Journal:  Eur Geriatr Med       Date:  2020-01-02       Impact factor: 1.710

Review 6.  Meaningful outcome measures in cardiac surgery.

Authors:  Paul S Myles
Journal:  J Extra Corpor Technol       Date:  2014-03

7.  Melatonin and Sleep in Preventing Hospitalized Delirium: A Randomized Clinical Trial.

Authors:  Stuti J Jaiswal; Thomas J McCarthy; Nathan E Wineinger; Dae Y Kang; Janet Song; Solana Garcia; Christoffel J van Niekerk; Cathy Y Lu; Melissa Loeks; Robert L Owens
Journal:  Am J Med       Date:  2018-05-03       Impact factor: 4.965

8.  Neurological examination of critically ill patients: a pragmatic approach. Report of an ESICM expert panel.

Authors:  Tarek Sharshar; Giuseppe Citerio; Peter J D Andrews; Arturo Chieregato; Nicola Latronico; David K Menon; Louis Puybasset; Claudio Sandroni; Robert D Stevens
Journal:  Intensive Care Med       Date:  2014-02-13       Impact factor: 17.440

9.  Hospital Elder Life Program: Systematic Review and Meta-analysis of Effectiveness.

Authors:  Tammy T Hshieh; Tinghan Yang; Sarah L Gartaganis; Jirong Yue; Sharon K Inouye
Journal:  Am J Geriatr Psychiatry       Date:  2018-06-26       Impact factor: 4.105

10.  Cyclooxygenase-1-dependent prostaglandins mediate susceptibility to systemic inflammation-induced acute cognitive dysfunction.

Authors:  Éadaoin W Griffin; Donal T Skelly; Carol L Murray; Colm Cunningham
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.